Asymmetric Total Synthesis of (−)-Azaspirene, a Novel Angiogenesis Inhibitor

Yujiro Hayashi,* Mitsuru Shoji, Junichiro Yamaguchi, Kenji Sato, Shinpei Yamaguchi, Takasuke Mukaiyama, Ken Sakai,§ Yukihiro Asami, Hideaki Kakeya, and Hiroyuki Osada
Department of Industrial Chemistry, Faculty of Engineering, and Department of Applied Chemistry, Faculty of Science, Tokyo University of Science, Kagurazaka, Shinjuku-ku, Tokyo 162-8601, Japan, and Antibiotics Laboratory, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
J. Am. Chem. Soc., 2002, 124 (41), pp 12078–12079
DOI: 10.1021/ja0276826
Publication Date (Web): September 18, 2002
Copyright © 2002 American Chemical Society
*

 To whom correspondence should be addressed. E-mail:  hayashi@ ci.kagu.tus.ac.jp.

,

 Department of Industrial Chemistry, Faculty of Engineering, Tokyo University of Science.

,
§

 Department of Applied Chemistry, Faculty of Science, Tokyo University of Science.

,

 Antibiotics Laboratory, RIKEN.

Abstract

Abstract Image

The asymmetric total synthesis of (−)-azaspirene, an angiogenesis inhibitor, has been accomplished, establishing its absolute stereochemistry. The key steps are a MgBr2·OEt2-mediated, diastereoselective Mukaiyama aldol reaction, a NaH-promoted, intramolecular cyclization of an alkynylamide, and the aldol reaction of a ketone containing functionalized γ-lactam moiety without protection of tert-alcohol and amide functionalities.

Tools

History

  • Published In Issue October 16, 2002
  • Received July 12, 2002

Recommend & Share

Related Content

Other ACS content by these authors: